[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100658092":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":11,"studyPopulation":11,"armGroups":19,"interventions":31,"overallOfficials":41,"centralContacts":49,"locations":54,"responsibleParty":94,"collaborators":96,"id":98,"slug":99,"hasResults":100,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":11,"eligibilityCriteria":104,"healthyVolunteers":100,"sex":105,"minAge":106,"maxAge":107,"enrollmentInfo":108,"targetDuration":11,"studyType":111,"phases":112,"briefSummary":114,"conditions":115,"keywords":11,"overallStatus":117,"whyStopped":11,"lastUpdateSubmitDate":118,"lastUpdatePostDateStruct":119,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":127},{"fullName":5,"class":6},"CooperVision International Limited (CVIL)","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Change in axial length (AXL, mm) over 12 months",null,"Over 12 months",{"allocation":14,"interventionModel":15,"interventionModelDescription":11,"primaryPurpose":16,"observationalModel":11,"timePerspective":11,"maskingInfo":17},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":18,"maskingDescription":11,"whoMasked":11},"NONE",[20,26],{"label":21,"type":22,"description":23,"interventionNames":24},"Test Group","EXPERIMENTAL","Participants will wear Test Spectacle Lens \\& Contact Lenses",[25],"Device: Test Spectacle Lens & Contact Lens",{"label":27,"type":22,"description":28,"interventionNames":29},"Control Group","Participants will wear Control Spectacle Lens \\& Contact Lenses",[30],"Device: Control Spectacle Lens & Contact Lens",[32,37],{"type":33,"name":34,"description":35,"armGroupLabels":36,"otherNames":11},"DEVICE","Test Spectacle Lens & Contact Lens","Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and test spectacle lenses for remaining waking hours.",[21],{"type":33,"name":38,"description":39,"armGroupLabels":40,"otherNames":11},"Control Spectacle Lens & Contact Lens","Participants will wear contact lenses for a target of 10 hours a day, 5 days per week and control spectacle lenses for remaining waking hours.",[27],[42,46],{"name":43,"affiliation":44,"role":45},"Baskar Arumugam, PhD","CooperVision, Inc.","STUDY_CHAIR",{"name":47,"affiliation":48,"role":45},"Debbbie Laughton","SightGlass Vision, Inc.",[50],{"name":43,"role":51,"phone":52,"phoneExt":11,"email":53},"CONTACT","1(925) 353-8468","barumugam@coopervision.com",[55,77],{"facility":56,"status":11,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"Centre for Ocular Research & Education (CORE) School of Optometry & Vision Science University of Waterloo","Waterloo","Ontario","N2L 3Gi","Canada","CA",{"type":63,"coordinates":64},"Point",[65,66],-80.51639,43.4668,{"lat":66,"lon":65},[69,73,75],{"name":70,"role":51,"phone":71,"phoneExt":11,"email":72},"Jill Woods","1-519 888 4567 ext 436743","jwoods@uwaterloo.ca",{"name":70,"role":74,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"name":76,"role":74,"phone":11,"phoneExt":11,"email":11},"Deborah Jones",{"facility":78,"status":11,"city":79,"state":11,"zip":80,"country":81,"countryCode":82,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Aston University","Birmingham","B4 7ET","United Kingdom","UK",{"type":63,"coordinates":84},[85,86],-1.89983,52.48142,{"lat":86,"lon":85},[89,93],{"name":90,"role":51,"phone":91,"phoneExt":11,"email":92},"Nicola Logan","0121 204 4128","n.s.logan@aston.ac.uk",{"name":90,"role":74,"phone":11,"phoneExt":11,"email":11},{"type":95,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[97],{"name":48,"class":6},"100658092","using-contact-lenses-and-spectacle-lenses-as-myopia-interventions-100658092",false,"NCT07845721","Using Contact Lenses and Spectacle Lenses as Myopia Interventions.","Twelve-Month Outcomes in Children Using MiSight® 1-Day Contact Lenses and Myopia Control Spectacle Lenses as Complementary Myopia Control Interventions.","Inclusion Criteria:\n\n* Are aged 11 to 17 years (inclusive);\n* Have successfully completed the 4-year MiSight® Analysis of Progression (MAP) Study;\n* Are established soft contact lens wearers (including myopia control contact lens designs);\n* Have read and signed the study consent or assent form, as appropriate for their age;\n* Have a parent or legal guardian who has read and signed the Parent\u002FGuardian Information Sheet (PIS) and Consent Form;\n* Are willing and able to follow study instructions and maintain the appointment schedule;\n* Are willing to wear the study contact lenses for 10 hours\u002Fday and 5 days per week as an ideal target while participating;\n* Require a spherical contact lens power correction between -0.50 and -6.00 D;\n* Have astigmatism not exceeding 2.00 DC in each eye by subjective refraction;\n* Have best-corrected visual acuity of 0.10 logMAR (approx. 20\u002F25 Snellen) or better in each eye;\n* Have ocular health findings (biomicroscopy) that do not contraindicate contact lens wear;\n* Continue to demonstrate acceptable fit and handling with the study contact lenses.\n\nExclusion Criteria:\n\n* Are participating in any concurrent clinical or interventional study;\n* Have worn rigid gas-permeable (including orthokeratology) contact lenses within the previous 30 days;\n* Have used atropine concentrations above 0.01% for myopia control in the previous 30 days;\n* Are extended-wear contact lens users (i.e., sleep in their lenses);\n* Have best-corrected visual acuity worse than 0.10 logMAR in either eye;\n* Have any current or evolving ocular or systemic condition that could affect visual function, ocular growth, or contact lens wear;\n* Have any clinically significant corneal or conjunctival staining with sodium fluorescein, or other ocular findings contraindicating contact lens wear;\n* Are using systemic or topical medications known or expected to affect pupil size, tear production, accommodation, refractive state, or any study outcome variable;\n* Have a history of ocular surgery, keratoconus, or other forms of irregular cornea, or are aphakic;\n* Have diagnosed accommodative and\u002For binocular vision anomalies, including amblyopia, strabismus, or nystagmus;\n* Have known sensitivity or allergy to any of the diagnostic agents used in the study;\n* Have any systemic condition that, in the opinion of the investigator, may influence study outcomes or contraindicate soft contact lens wear, including pregnancy;\n* Are a child of an employee of either clinical site directly involved in the study.","ALL","11 Years","17 Years",{"count":109,"type":110},58,"ESTIMATED","INTERVENTIONAL",[113],"NA","Effect of alternating contact lenses and spectacles for myopia control.",[116],"Myopia","NOT_YET_RECRUITING","2026-09-22",{"date":120,"type":121},"2026-09-29","ACTUAL",{"date":123,"type":110},"2026-09",{"date":125,"type":110},"2028-02",{"name":5,"class":6},2]